Ignite Creation Date:
2024-05-06 @ 5:21 PM
Last Modification Date:
2024-10-26 @ 2:27 PM
Study NCT ID:
NCT05274464
Status:
COMPLETED
Last Update Posted:
2022-03-25
First Post:
2022-03-02
Brief Title:
A Recurrence Nomogram for Hepatoid Adenocarcinoma of the Stomach
Sponsor:
Fujian Medical University
Organization:
Fujian Medical University
Study Overview
Official Title:
A Recurrence Nomogram to Guide Surveillance Strategies After the Resection of Hepatoid Adenocarcinoma of the Stomach a China Hepatoid Adenocarcinoma of the Stomach Study Group Database Study
Status:
COMPLETED
Status Verified Date:
2022-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study aims to develop a nomogram to predict postoperative recurrence of HAS and guide individually tailored surveillance strategies
Detailed Description:
Patients were included from the China Hepatoid Adenocarcinoma of the Stomach Study Group China-HASSG database which comprises 14 tertiary referral centers All the patients who had undergone complete resection of a primary HAS between April 2004 and December 2019 were included First univariate analysis was performed in Cox regression to identify the risk factors associated with RFS Next variables with P 005 in univariable analysis were included in the multivariable model and the forward likelihood ratio method was used for analysis to confirm the independent prognostic factors associated with RFS Finally based on the results of multivariable analysis variables that achieved significance at P 005 were selected to formulate a nomogram
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None